ORAGENICS, INC. Accrued Bonuses, Current
ORAGENICS, INC. (OGEN) had Accrued Bonuses, Current of $247.68 thousand as of 2020-12-31, per its 10-K/A filed 2022-07-29.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2022-07-29
- 2020-12-31: Accrued Bonuses, Current $247.68K.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2020-12-31 | $247.68K 10-K/A · filed 2022-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |